Minji Jeon
Seoul
Summary
Develops evidence-based Market Access strategies by integrating clinical and epidemiological evidence, real-world evidence, and health technology assessment (HTA) to support reimbursement decisions. Leads reimbursement and Risk-Sharing Agreement (RSA) reassessment projects, contributing to successful reimbursement and coverage maintenance across diverse therapeutic areas.
Overview
7
7
years of professional experience
Work History
Market access
NDnex
Seoul
06.2021 - Current
- Developed evidence-based reimbursement strategies integrating clinical, epidemiological, real-world, and HTA evidence, resulting in successful new drug listings and reimbursement decisions in Korea.
- Led reimbursement and Risk-Sharing Agreement (RSA) reassessment projects, identifying key evaluation issues and strengthening supporting evidence to maintain reimbursement coverage.
- Leveraged cross-project experience across pharmaceutical companies and therapeutic areas to anticipate payer perspectives and develop targeted product-specific evidence and Market Access strategies.
PR consultant
Enzaim Health
Seoul
09.2020 - 03.2021
- Managed prescription drug PR campaigns across multiple therapeutic areas, creating media and digital communication strategies informed by product, disease, and clinical insights to enhance audience engagement.
- Conducted media monitoring, coverage and Share of Voice (SOV) analysis, and tracked campaign performance against key performance indicators (KPIs) to optimize communication strategies.
- Coordinated with pharmaceutical clients, healthcare professionals, media, and external partners to develop targeted communication materials and execute integrated online and offline PR activities, ensuring consistent messaging and outreach.
Intern
Macoll Consulting Group
Seoul
12.2019 - 06.2020
- Assisted in executing PR campaigns for prescription drugs across various therapeutic areas, gaining practical experience in pharmaceutical communications.
- Conducted monitoring of disease trends and product performance, analysed media coverage, and performed market research to inform PR strategies and campaign planning.
- Developed press releases, media materials, and digital content, coordinating with internal teams and external partners to effectively implement PR activities.
Education
[Bachelor's degree] - Department of Media communication
Chung-Ang University
Seoul01-2019
[Master's degree] - Department of Pharmaceutical Industry
Ewha Womans University
SeoulSkills
- Market access strategy
- Reimbursement analysis
- Reimbursement and RSA reassessment
- Cost-effectiveness analysis
- Budget Impact Analysis
- HTA evidence
- Indirect Treatment Comparison
- Pharmaceutical Economic Evaluation
Breakdown type of work
- Pharmacoeconomics: 21 projects
- Dossier development: 17 projects
- RSA re-evaluation(including CUA, dossier updates): 11 projects
- ITCs: 1 project
- Reimbursement re-evaluation: 5 projects
Timeline
Market access
NDnex
06.2021 - Current
PR consultant
Enzaim Health
09.2020 - 03.2021
Intern
Macoll Consulting Group
12.2019 - 06.2020
[Bachelor's degree] - Department of Media communication
Chung-Ang University
[Master's degree] - Department of Pharmaceutical Industry
Ewha Womans University